SCHEMBL8975688

SCHEMBL8975688

O=C(NCCCN1CCCCCC1)C(c1cc2ccccc2s1)C1CCCCC1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.66
CYP1A2 P05177 1/20 0.66
CYP3A4 P08684 1/20 0.66
CYP2D6 P10635 1/20 0.66
TSHR P16473 1/20 0.66
TDP1 Q9NUW8 1/20 0.66
SLC6A2 P23975 2/20 0.52
SLC6A4 P31645 2/20 0.52
TACR2 P21452 5/20 0.49
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
RAD52 P43351 1/20 0.48
DRD2 P14416 2/20 0.47
DRD3 P35462 2/20 0.47
KDM4E B2RXH2 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL194768 0.80 TP53 (1.00) TP53CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL4876834 0.78 TP53 (0.98) TP53CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL14430767 0.76 SLC6A2 (0.70) SLC6A2SLC6A4TACR2ADRA1DADRA1A
SCHEMBL8975472 0.74 TP53 (0.72) TP53CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL18502023 0.72 SLC6A2 (0.69) SLC6A2SLC6A4TACR2ADRA1DADRA1A
SCHEMBL4877646 0.71 TP53 (0.84) TP53CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL8975590 0.68 RAB9A (0.80) TP53CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL718693 0.68 HSD17B2 (0.46) CYP1A2SLC6A2
SCHEMBL4284931 0.68 DRD4 (0.45) SLC6A4DRD2
SCHEMBL12918735 0.66 HRH4 (0.67) SLC6A2SLC6A4DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0475844-B1 Use of N-(1.hexahydroazepinylalkyl) acetamides for the manufacture of medicaments for the treatment of disorders of the cholineogic transmission UNIV CAEN (FR) 1996-04-17 EP claimed
US-5200405-A USE OF N-(1-HEXAHYDROAZEPINYLALKYL) ACETAMIDES FOR THE TREATMENT OF CHOLINERGIC TRANSMISSION DISORDERS ADIR ET COMPAGNIE (FR) 1993-04-06 US claimed
US-5200405-A USE OF N-(1-HEXAHYDROAZEPINYLALKYL) ACETAMIDES FOR THE TREATMENT OF CHOLINERGIC TRANSMISSION DISORDERS ADIR ET COMPAGNIE (FR) 1993-04-06 US disclosed